Your session is about to expire
← Back to Search
Targeted Radiation + Drug Therapy for Breast Cancer
Study Summary
This trial is testing whether adding SBRT to the usual cancer drug therapy can help people with oligometastatic breast cancer by preventing the cancer from worsening in other metastatic sites or spreading.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 4 trial • 19 Patients • NCT01344356Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My treatment for cancer has been working for at least 6 months without getting worse.I have a serious health condition that prevents me from receiving radiation therapy.My breast cancer has spread, confirmed by a biopsy.The cancer has only gotten worse in one specific area as shown on a PET scan.I am fully active or can carry out light work.I've had radiation before where they now want to treat, and can't have more without risking harm.I have or had a brain tumor.My cancer is mainly driven by estrogen receptors.My cancer is HER2 positive, no matter the ER status.I am 18 years old or older.
- Group 1: Participants with oligometastatic breast cancer
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any harmful side effects to Stereotactic body radiotherapy?
"Although there is some data supporting its safety, the lack of evidence for efficacy gives stereotactic body radiotherapy a score of 2."
How many individuals are experiencing this treatment?
"That is correct. The information available on clinicaltrials.gov reveals that this trial posted on September 6th, 2020 is still recruiting patients. 40 participants are needed and they will be chosen from 7 different locations."
Are people still being enrolled in this clinical trial?
"The trial, which was initially posted on September 6th of this year, is currently recruiting according to the website clinicaltrials.gov"
In how many different locations is this research project being conducted?
"There are 7 available for this trial such as Memorial Sloan Kettering Monmouth (Limited Protocol Activities) in Middletown, Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities) in Basking Ridge, and Memorial Sloan Kettering Westchester (Limited Protocol Activities) in Harrison. Other locations include 7 other locations."
Share this study with friends
Copy Link
Messenger